Clomiphene
Other / unclassified targets ESR1
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | CLOMID | — | 1967-02-01 | fda.gov ↗ |
Trials 65 · started per year
Also used as a comparator or background therapy in 88 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT03681197 Comparator | Jun 2018 → Apr 2019 | infertility disorder | Elham Raafat | Unknown | No outcome recorded |
| Phase 0 | NCT03566225 Comparator | Jan 2018 → Feb 2021 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 0 | NCT01909141 Comparator | Aug 2013 → Feb 2014 | infertility disorder, polycystic ovary syndrome | Cairo University | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT03755037 Comparator | Jan 2017 → Apr 2018 | female infertility | Nesreen Abdel Fattah Abdullah Shehata | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT04916925 Background | Aug → Sep 2021 | letrozole toxicity, polycystic ovary syndrome, vitamin D deficiency | Ain Shams University | Unknown | No outcome recorded |
| Phase 1/2 | NCT00947713 Comparator | Aug 2009 → Aug 2010 | gonadal disorder | Royan Institute | Completed | No outcome recorded |
| Phase 214 trials | ||||||
| Phase 2 | NCT05231980 Background | Jun 2022 → May 2023 | polycystic ovary syndrome | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT03245827 Comparator | Apr 2019 → Oct 2021 | hypogonadotropic hypogonadism | Sandeep Singh Dhindsa, M.D., F.A.C.E | Terminated | No outcome recorded |
| Phase 2 | NCT03674385 Background | Jul 2018 → Mar 2019 | polycystic ovary syndrome | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT02656121 Background | Feb 2016 → Nov 2018 | polycystic ovary syndrome | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT02663830 Comparator | Jan 2016 → Jan 2017 | anovulation | Ain Shams University | Completed | No outcome recorded |
| Phase 2 | NCT02551367 Comparator | Oct 2015 → May 2016 | anovulation, polycystic ovary syndrome | mostafa gomaa hamid halawa | Unknown | No outcome recorded |
| Phase 2 | NCT02644304 Comparator | May 2015 → Oct 2016 | female reproductive system disorder | Woman's Health University Hospital, Egypt | Unknown | No outcome recorded |
| Phase 2 | NCT02380755 Comparator | Apr 2015 → Jan 2017 | hypogonadism, male, obesity disorder | University of Sao Paulo | Completed | No outcome recorded |
| Phase 2 | NCT02562664 Comparator | Jan → Jun 2014 | polycystic ovary syndrome | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT01904734 Comparator | Oct 2012 → Oct 2018 | hypogonadism, male | Phoenix VA Health Care System | Completed | No outcome recorded |
| Phase 2 | NCT00796289 Comparator | Feb → Dec 2009 | infertility disorder | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 2 | NCT01232075 Comparator | Sep 2008 → Nov 2010 | infertility disorder | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT00844350 Comparator | Oct 2006 → Sep 2007 | ovarian disorder | Tabriz University | Completed | No outcome recorded |
| Phase 2 | NCT00213148 Comparator | Mar 2005 → Dec 2007 | anovulation | EMD Serono | Completed | No outcome recorded |
| Phase 2/37 trials | ||||||
| Phase 2/3 | NCT05846906 Background | Oct 2021 → Apr 2022 | female infertility | Beni-Suef University | Completed | No outcome recorded |
| Phase 2/3 | NCT04870502 Comparator | Apr 2019 → Jul 2020 | polycystic ovary syndrome | Saudi German Hospital - Madinah | Completed | No outcome recorded |
| Phase 2/3 | NCT05702957 Comparator | Sep 2016 → Oct 2019 | female infertility, polycystic ovary syndrome | Services Institute of Medical Sciences, Pakistan | Completed | No outcome recorded |
| Phase 2/3 | NCT02775734 Comparator | May 2016 → Mar 2017 | polycystic ovary syndrome | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT02237755 Comparator | Oct → Nov 2014 | female infertility | University of Athens | Unknown | No outcome recorded |
| Phase 2/3 | NCT02381184 Comparator | Jun 2014 → Jul 2016 | infertility disorder | Benha University | Completed | No outcome recorded |
| Phase 2/3 | NCT00296465 Comparator | Feb → Nov 2005 | female infertility | Ferring Pharmaceuticals | Completed | No outcome recorded |
| Phase 310 trials | ||||||
| Phase 3 | NCT03059173 Background | Sep 2023 → Sep 2027 expected | polycystic ovary syndrome | University Hospital, Lille | Recruiting | No outcome recorded |
| Phase 3 | NCT03396380 Comparator | Jul 2017 → Mar 2018 | female infertility | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT03241472 Comparator | Feb 2016 → May 2017 | infertility disorder | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT02264847 Comparator | Oct 2014 → Apr 2017 | anovulation | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT01638988 Comparator | Sep → Nov 2013 | diabetes mellitus, polycystic ovary syndrome | Clinique Ovo | Withdrawn | No outcome recorded |
| Phase 3 | NCT01044862 Comparator | Jun 2010 → Oct 2013 | infertility disorder, pregnancy disorder | Yale University | Completed | No outcome recorded |
| Phase 3 | NCT00719186 Comparator | Feb 2009 → May 2013 | polycystic ovary syndrome, pregnancy disorder | Yale University | Completed | No outcome recorded |
| Phase 3 | NCT00427700 Comparator | Aug 2008 → Aug 2009 | polycystic ovary syndrome | Hospital de Clinicas de Porto Alegre | Completed | No outcome recorded |
| Phase 3 | NCT00610077 Comparator | Dec 2004 → Jul 2006 | infertility disorder | Sun Pharmaceutical Industries, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT00413179 Background | Dec 1997 → Apr 2003 | anovulation, infertility disorder, polycystic ovary syndrome | 59th Medical Wing | Completed | No outcome recorded |
| Phase 427 trials | ||||||
| Phase 4 | NCT07462065 Comparator | Mar → Jun 2026 overdue | female infertility | PAEC General Hospital, Islamabad | Recruiting | No outcome recorded |
| Phase 4 | NCT06178523 Comparator | Jan → Dec 2024 | infertility disorder | Batterjee Medical College | Completed | No outcome recorded |
| Phase 4 | NCT05753098 Background | Jan 2021 → Jan 2023 | female infertility | Beni-Suef University | Completed | No outcome recorded |
| Phase 4 | NCT04306692 Comparator | Jul 2020 → Apr 2021 | female infertility, polycystic ovary syndrome | University Hospital, Ghent | Terminated | No outcome recorded |
| Phase 4 | NCT04302532 Background | Jul → Sep 2020 | — | Karachi Medical and Dental College | Completed | No outcome recorded |
| Phase 4 | NCT04331197 Comparator | May 2020 → May 2021 | female infertility | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT04210765 Comparator | Aug 2019 → May 2020 | anovulation, infertility disorder | Bagcilar Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04010942 Comparator | Apr → Dec 2018 | polycystic ovary syndrome, vitamin D deficiency | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT03806036 Comparator | Jan 2018 → Feb 2019 | polycystic ovary syndrome | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT02690870 Comparator | Jan 2017 → May 2018 | infertility disorder | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Unknown | No outcome recorded |
| Phase 4 | NCT02330757 Comparator | Oct 2016 → Dec 2024 | infertility disorder | Mansoura University | Unknown | No outcome recorded |
| Phase 4 | NCT02890238 Comparator | Aug 2016 → Oct 2019 | female infertility | Cairo University | Unknown | No outcome recorded |
| Phase 4 | NCT02436226 Comparator | Mar 2016 → Jan 2023 | female infertility, polycystic ovary syndrome | Mohamed Sayed Abdelhafez | Completed | No outcome recorded |
| Phase 4 | NCT03630341 Background | Feb 2016 → Mar 2018 | polycystic ovary syndrome | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT02344888 Comparator | Feb 2015 → Jan 2019 | infertility disorder, polycystic ovary syndrome | Mahmoud Thabet | Unknown | No outcome recorded |
| Phase 4 | NCT02186782 Comparator | Jun 2014 → Jul 2018 | anovulation, infertility disorder | Maher elesawi kamel elesawi | Unknown | No outcome recorded |
| Phase 4 | NCT01577472 Comparator | Aug 2013 → Nov 2017 | female infertility, ovarian dysfunction | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase 4 | NCT02352597 Comparator | Jan 2013 → Jan 2015 | polycystic ovary syndrome | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT01219101 Background | Mar 2011 → Nov 2012 | infertility disorder | Royan Institute | Completed | No outcome recorded |
| Phase 4 | NCT01921166 Comparator | Jan → Nov 2011 | infertility disorder | Wake Forest University Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT00502229 Comparator | Jan 2010 → Jan 2011 | infertility disorder, polycystic ovary syndrome | University Magna Graecia | Withdrawn | No outcome recorded |
| Phase 4 | NCT02638285 Background | Jan → Aug 2009 | pregnancy disorder | Shiraz University of Medical Sciences | Completed | No outcome recorded |
| Phase 4 | NCT00835744 Comparator | Aug 2008 → Mar 2012 | infertility disorder | University Hospital Brussels | Completed | No outcome recorded |
| Phase 4 | NCT00501839 Comparator | Aug 2008 → Sep 2010 | infertility disorder, polycystic ovary syndrome | University Magna Graecia | Withdrawn | No outcome recorded |
| Phase 4 | NCT01004068 Comparator | Feb 2008 → Oct 2009 | anovulation, polycystic ovary syndrome | University Magna Graecia | Completed | No outcome recorded |
| Phase 4 | NCT00478504 Comparator | May 2007 → Jun 2014 | infertility disorder, polycystic ovary syndrome | University of Nottingham | Completed | No outcome recorded |
| Phase 4 | NCT00461643 Comparator | Jan 2007 → Dec 2015 | polycystic ovary syndrome | University Magna Graecia | Unknown | No outcome recorded |
| Phase not applicable24 trials | ||||||
| — | NCT07568574 Background | Mar 2026 → May 2028 expected | — | Enhanced Emirates Limited | Enrolling by invitation | No outcome recorded |
| — | NCT06635538 Background | Oct 2024 → Apr 2025 overdue | female infertility | Fundacion Dexeus | Recruiting | No outcome recorded |
| — | NCT06507332 Comparator | Mar → Sep 2024 | polycystic ovary syndrome | Egymedicalpedia | Unknown | No outcome recorded |
| — | NCT05670795 Comparator | Jan 2023 → May 2024 | infertility disorder | Bezmialem Vakif University | Unknown | No outcome recorded |
| — | NCT07398924 Background | Jan 2022 → Jun 2023 | anovulation, female infertility | Yuzuncu Yil University | Completed | No outcome recorded |
| — | NCT05106712 Comparator | Nov 2021 → Jul 2023 | female infertility, polycystic ovary syndrome, vitamin D deficiency | Umm Al-Qura University | Unknown | No outcome recorded |
| — | NCT05089344 Background | Oct 2021 → Oct 2022 | female infertility | Ain Shams Maternity Hospital | Unknown | No outcome recorded |
| — | NCT04170439 Background | Nov 2019 → May 2020 | — | Aljazeera Hospital | Completed | No outcome recorded |
| — | NCT03398993 Comparator | Jan → Dec 2018 | infertility disorder | Cairo University | Unknown | No outcome recorded |
| — | NCT03301233 Background | Nov 2017 → Jul 2018 | — | Ain Shams University | Completed | No outcome recorded |
| — | NCT03476356 Background | Nov 2017 → Mar 2018 | polycystic ovary syndrome | Ain Shams University | Completed | No outcome recorded |
| — | NCT02865681 Background | Jul 2016 → Jun 2017 | infertility disorder | New Hope Fertility Center | Completed | No outcome recorded |
| — | NCT02137265 Comparator | Sep 2015 → Oct 2020 | azoospermia, hypogonadism, male | University of Illinois at Chicago | Withdrawn | No outcome recorded |
| — | NCT02710981 Background | Jun 2015 → Jan 2016 | anovulation | Assiut University | Completed | No outcome recorded |
| — | NCT02520505 Comparator | Apr 2015 → Dec 2017 | endometriosis, female infertility | The Cleveland Clinic | Withdrawn | No outcome recorded |
| — | NCT02345837 Comparator | Feb 2014 → Sep 2016 | — | Al Hayat National Hospital | Unknown | No outcome recorded |
| — | NCT02294773 Comparator | Oct 2013 → Sep 2015 | infertility disorder | Midwest Fertility Specialists | Completed | No outcome recorded |
| — | NCT01793038 Comparator | Mar 2013 → Jun 2014 | infertility disorder, polycystic ovary syndrome | Mansoura Integrated Fertility Center | Unknown | No outcome recorded |
| — | NCT01607320 Comparator | Jun 2012 → Mar 2013 | polycystic ovary syndrome | Bruce Lessey | Terminated | No outcome recorded |
| — | NCT01291056 Comparator | Jan 2010 → May 2011 | — | University of Utah | Completed | No outcome recorded |
| — | NCT01679574 Comparator | Jan 2009 → Jan 2012 | polycystic ovary syndrome | Assiut University | Completed | No outcome recorded |
| — | NCT01334762 Comparator | May 2007 → Jun 2010 | endometriosis | Mansoura University | Completed | No outcome recorded |
| — | NCT01008046 Background | Apr 2007 → Jun 2009 | polycystic ovary syndrome | Mansoura University | Completed | No outcome recorded |
| — | NCT00911313 Comparator | Jun 2006 → Jan 2009 | polycystic ovary syndrome | Mansoura University | Completed | No outcome recorded |
Evidence & citations 26 cited values
Every value below carries the sentence it was read from. 158 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | clomiphene | “100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664 ↗31“Drug: Clomiphene” NCT01679574 ↗ |
| Known as | Chloramiphene | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Clomid | “All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation.” NCT01157312 ↗16“induction of ovulation with clomiphene citrate (Clomid®, Aventis) 50 mg tablet twice daily starting from the third day of menstrual cycle and for 5 days” PMID 32363556 ↗ May 2020 “Clomid 50 mg per day will be administered orally and human chorionic gonadotrophin ( choriomon ) 5000 IU will be administered IM once per week.” NCT01529177 ↗ “Thirty PCOS patients treated with 3 cycles of 100mg/day of Clomid (clomiphene citrate) on days 3 to 7 following an initial provera withdrawal” NCT01607320 ↗ “Clomiphene citrate(Clomid; Aventis pharma S.AE, Global Napi pharmaceuticals, Cairo, Egypt) 100 mg/day is administered from cycle day 3 to 7.” NCT01232075 ↗ “100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664 ↗ “patients in either group received 100 mg CC (Clomid®; Global Napi Pharmaceuticals,Cairo, Egypt)” NCT01008046 ↗ “Clomiphene citrate 50 mg tab oral tablets(Clomid 50 mg tablets Global Napi , Egypt)” NCT01212263 ↗ “Clomiphene citrate (Clomid) is often used for assisted reproductive technologies” NCT06701071 ↗ “Clomid is the standard first drug of treatment for ovulation induction” NCT01793038 ↗ “Clomiphene citrate (clomid) (50mg) will be given for 5 days” NCT03178500 ↗ “oral Clomiphene Citrate (Clomid®) 150 mg/day for 5 days” NCT04157725 ↗ “clomiphene citrate (clomid 50mg ®, Sanofi aventis)” NCT03301233 ↗ |
| Known as | Clomifene | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Clomifene Citrate | “clomifene citrate 50 mg three times daily” NCT04052607 ↗ |
| Known as | Clomifeni citras | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Clomifeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | clomiphen citrate | “100mg of clomiphencitrate(Serophene®) are added to a high dose of HMG (450 IU of Merional®) in the early follicular phase of the stimulation (day 3 to 7).” NCT01577472 ↗1“Initial clomiphen citrate (CC) doses were 50 mg daily for 5 days starting on cycle day 3.” NCT02269306 ↗ |
| Known as | Clomiphene Citrate | “OBJECTIVE: To evaluate pregnancy rates with letrozole and clomiphene citrate (CC) alone for superovulation in an intrauterine insemination program for women with recently...” PMID 22181973 ↗ Jan 2012122“Clomiphene citrate (Ovumid®, Iran Hormones Company) 25 mg/day with co-treatment of Letrozole (Letrofem®, Iran Hormones Company) 2.5 mg/day are given from cycle day 3 onwards.” NCT02732808 ↗ “Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.” PMID 33367742 ↗ Mar 2021 “Following ovulation or no response to increasing clomiphene-citrate doses, correlations between predictors and treatment responses were analyzed.” PMID 26848057 ↗ Dec 2015 “Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With HMG in PCOs Patients With Previous Clomiphene Citrate (CC)-Resistant Anovulation” NCT00947713 ↗ “Letrozole Versus Combined Metformin and Clomiphene Citrate for Ovulation Induction in Clomiphene-Resistant Women With Polycystic Ovary Syndrome” NCT00911313 ↗ “Thirty PCOS patients treated with 3 cycles of 100mg/day of Clomid (clomiphene citrate) on days 3 to 7 following an initial provera withdrawal” NCT01607320 ↗ “Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)” NCT00969631 ↗ “Clomiphene citrate, a selective estrogen-receptor modulator that antagonizes the negative feedback of estrogen at the hypothalamus” NCT04361175 ↗ “Clomiphene citrate is a well-established agent that has been empirically used in cases of idiopathic oligospermia.” PMID 16291975 ↗ Nov 2005 “Clomiphene citrate (CC) is a commonly prescribed pharmacologic agent used to induce ovulation in women with PCOS.” NCT06507332 ↗ “Clomiphene citrate 100mg (2 tablets clomid 50mg each per day,from 2nd to 6th day of the cycle ) will be added” NCT04010942 ↗ “100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664 ↗ “Clomiphene citrate, a SERM that increases luteinizing hormone and follicle stimulating hormone secretion” NCT02274311 ↗ “clomiphene citrate 50 mg tablets twice /day for 5 days plus 37.5 IU uFSH IM injections daily for 10 days” NCT01793038 ↗ “CLOMID (clomiphene citrate tablets USP) is an orally administered, nonsteroidal, ovulatory stimulant” NCT04619914 ↗ “Each tablet contains 50 mg of clomiphene citrate which means 33,9 mg of clomiphene.” NCT04306692 ↗ “Clomiphene citrate 50 mg tab oral tablets(Clomid 50 mg tablets Global Napi , Egypt)” NCT01212263 ↗ “Clomiphene citrate is a well known selective estrogen receptor modulator” NCT00697814 ↗ “Oral clomiphene citrate: 100 mg/day until the day of the triggering.” NCT02448459 ↗ “Oral clomiphene citrate: 100 mg/day until the day of the triggering.” NCT02288143 ↗ “N-acetyl cysteine and clomiphene citrate(CC)with combined metformin” NCT01008046 ↗ “patients received a 50-mg dose of clomiphene citrate.” PMID 26848057 ↗ Dec 2015 “clomiphene citrate (clomid 50mg ®, Sanofi aventis)” NCT03301233 ↗ “Clomiphene Citrate for induction of ovulation” NCT02656121 ↗ “Experimental: Clomiphene Citrate (CC) + rFSH” NCT04983173 ↗ “Drug: Clomiphene citrate” NCT01638988 ↗ “Clomiphene Citrate 25mg” NCT03933618 ↗ |
| Known as | Clomiphene citrate (1:1) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Clophene | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Clostilbegyt | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Ikaclomine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | MER-41 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Milophene | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | MRL-41 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | NSC-35770 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Omifin | “CC 50 mg/day (Omifin®) + rFSH 150 IU (Ovaleap®)” NCT04983173 ↗ |
| Known as | Ovumid | “Clomiphene citrate (Ovumid®, Iran Hormones Company) 25 mg/day with co-treatment of Letrozole (Letrofem®, Iran Hormones Company) 2.5 mg/day are given from cycle day 3 onwards.” NCT02732808 ↗ |
| Known as | Pergotime | ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051 ↗ |
| Known as | Serophene | “100mg of clomiphencitrate(Serophene®) are added to a high dose of HMG (450 IU of Merional®) in the early follicular phase of the stimulation (day 3 to 7).” NCT01577472 ↗ |
| Known as | Tecnovula | “clomiphene citrate 50 mg (Tecnovula®)” NCT05753098 ↗ |
| Action | Activate | “Traditionally, clomiphene citrate, an estrogen receptor agonist, is the most used drug for this type of anovulation.” NCT00427700 ↗ |
| Modality | Other / unclassified | “Clomiphene citrate, a selective estrogen receptor modulator (SERM) oral medication which inhibits estrogen effects (feedback) on the brain” NCT01880086 ↗ |
| Route | Oral | “oral clomiphene citrate daily” NCT00005104 ↗ |
| Target | ESR1 | “Estrogen receptor alpha modulator” CHEMBL2355051 ↗ |